# Hikma Pharmaceuticals PLC (HKMPF)

> Healthcare · GB · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/HKMPF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 1.70B | $ 219.77M | $ 46.32M | $ 1.95B | $ 2.52B |
| 2025 | $ 3.44B | $ 412.63M | $ 199.34M | $ 1.60B | $ 2.60B |
| 2024 | $ 3.29B | $ 377.34M | $ 419.38M | $ 1.31B | $ 2.31B |
| 2023 | $ 3.11B | $ 205.44M | $ 474.67M | $ 1.19B | $ 2.20B |
| 2022 | $ 2.81B | $ 210.02M | $ 437.91M | $ 1.28B | $ 2.14B |
| 2021 | $ 3.03B | $ 500.42M | $ 586.01M | $ 846.00M | $ 2.45B |
| 2020 | $ 2.98B | $ 549.06M | $ 371.99M | $ 932.00M | $ 2.14B |
| 2019 | $ 2.85B | $ 627.30M | $ 455.63M | $ 685.00M | $ 2.12B |
| 2018 | $ 2.73B | $ 372.43M | $ 426.58M | $ 637.00M | $ 1.69B |
| 2017 | $ 2.61B | $ -1.14B | $ 452.64M | $ 777.00M | $ 1.51B |
| 2016 | $ 2.68B | $ 213.25M | $ 235.27M | $ 860.00M | $ 2.40B |
| 2015 | $ 2.02B | $ 353.82M | $ 398.75M | $ 728.00M | $ 1.34B |
| 2014 | $ 2.10B | $ 392.82M | $ 471.95M | $ 562.00M | $ 1.20B |
| 2013 | $ 1.94B | $ 301.51M | $ 395.38M | $ 442.00M | $ 1.02B |
| 2012 | $ 1.60B | $ 144.38M | $ 132.79M | $ 584.74M | $ 832.65M |
| 2011 | $ 1.35B | $ 122.63M | $ 36.20M | $ 519.18M | $ 776.57M |
| 2010 | $ 1.11B | $ 150.70M | $ 129.60M | $ 167.42M | $ 743.92M |
| 2009 | $ 964.33M | $ 120.10M | $ 98.62M | $ 184.94M | $ 675.89M |
| 2008 | $ 879.20M | $ 86.49M | $ -11.58M | $ 234.43M | $ 603.21M |
| 2007 | $ 679.54M | $ 97.20M | $ -17.97M | $ 341.35M | $ 418.48M |
| 2006 | $ 480.02M | $ 84.73M | $ -33.99M | $ 66.61M | $ 345.07M |
| 2005 | $ 397.03M | $ 66.42M | $ 13.22M | $ 54.14M | $ 283.88M |
| 2004 | $ 321.57M | $ 57.82M | $ 17.43M | $ 15.75M | $ 36.29M |
| 2003 | $ 159.21M | $ 26.89M | $ 18.25M | $ 15.84M | $ 60.08M |
| 2002 | $ 129.46M | $ 16.01M | $ 17.81M | $ 22.54M | $ 47.75M |
| 2001 | N/A | N/A | $ 5.43M | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.78 |
| Liabilities / Eq | 1.30 |
| Current Ratio | 1.98 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 7.91 |
| Gross Debt / FCF | 4.83 |

## Other views

- [Metrics](https://sponda.capital/en/HKMPF.md)
- [Charts](https://sponda.capital/en/HKMPF/charts.md)
- [Compare](https://sponda.capital/en/HKMPF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.